Literature DB >> 26143430

Granulomatous Drug Eruptions.

Roni P Dodiuk-Gad1, Neil H Shear2.   

Abstract

Granuloma formation is usually regarded as a means of defending the host from persistent irritants of either exogenous or endogenous origin. Noninfectious granulomatous disorders of the skin encompass a challenging group of diseases owing to their clinical and histologic overlap. Drug reactions characterized by a granulomatous reaction pattern are rare, and defined by a predominance of histiocytes in the inflammatory infiltrate. This review summarizes current knowledge on the various types of granulomatous drug eruptions, focusing on the 4 major types: interstitial granulomatous drug reaction, drug-induced accelerated rheumatoid nodulosis, drug-induced granuloma annulare, and drug-induced sarcoidosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug; Granuloma; Granulomatous drug eruptions; Noninfectious granuloma; Skin

Mesh:

Substances:

Year:  2015        PMID: 26143430     DOI: 10.1016/j.det.2015.03.015

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  6 in total

Review 1.  Cutaneous Granulomatosis: a Comprehensive Review.

Authors:  Benedetta Terziroli Beretta-Piccoli; Carlo Mainetti; Marie-Astrid Peeters; Emmanuel Laffitte
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Delayed granulomatous eruption of the nose associated with ruxolitinib.

Authors:  Margaret Brown; Katherine Smith; Sandra Osswald
Journal:  JAAD Case Rep       Date:  2020-05-13

3.  Pulmonary granulomatous inflammation after ceritinib treatment in advanced ALK-rearranged pulmonary adenocarcinoma.

Authors:  Juanyan Liao; Hui Guan; Min Yu; Ping Zhou; Yao Han; Xingchen Peng; Shuang Zhang
Journal:  Invest New Drugs       Date:  2022-06-21       Impact factor: 3.651

4.  Granulomatous drug eruption associated with imipramine.

Authors:  Anabella Pascucci
Journal:  JAAD Case Rep       Date:  2018-01-16

5.  Drug-induced sarcoidosis in a patient treated with an interleukin-1 receptor antagonist for hidradenitis suppurativa.

Authors:  Blake E Friedman; Joseph C English
Journal:  JAAD Case Rep       Date:  2018-06-06

Review 6.  Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review.

Authors:  Jo L W Lambert; Sofie De Schepper; Reinhart Speeckaert
Journal:  J Clin Med       Date:  2021-03-03       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.